LIMN · Company research
Liminatus Pharma, Inc. Class A Common Stock (LIMN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Liminatus Pharma Inc Cl A (LIMN-Q) Stock Price and News - The Globe and Mail | Liminatus Pharma Inc Cl A (LIMN-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 2, 2026 | neutral | 0 | 0.6 |
| Press Releases about Liminatus Pharma, Inc. - Class A Common Stock (Nasdaq:LIMN) - FinancialContent | Press Releases about Liminatus Pharma, Inc. - Class A Common Stock (Nasdaq:LIMN) FinancialContent | View source ↗ | FinancialContent | Aug 20, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma to implement 1-for-50 reverse stock split - Investing.com | Liminatus Pharma to implement 1-for-50 reverse stock split Investing.com | View source ↗ | Investing.com | Aug 18, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Bid Price Compliance - Quiver Quantitative | Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Bid Price Compliance Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement - The Manila Times | Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement The Manila Times | View source ↗ | The Manila Times | Aug 13, 2026 | neutral | 0 | 0.6 |
| Price to book forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView | Price to book forward of Liminatus Pharma, Inc. – NASDAQ:LIMN TradingView | View source ↗ | TradingView | Jul 5, 2026 | neutral | 0 | 0.6 |
| Thursday's session: gap up and gap down stocks - ChartMill | Thursday's session: gap up and gap down stocks ChartMill | View source ↗ | ChartMill | Jul 2, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga | Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio Benzinga | View source ↗ | Benzinga | Jul 2, 2026 | neutral | 0 | 0.6 |
| Thursday's session: most active stocks - ChartMill | Thursday's session: most active stocks ChartMill | View source ↗ | ChartMill | Jul 2, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance with Market Value Requirements - Quiver Quantitative | Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance with Market Value Requirements Quiver Quantitative | View source ↗ | Quiver Quantitative | May 22, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Session - Benzinga | Liminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Session Benzinga | View source ↗ | Benzinga | May 21, 2026 | neutral | 0 | 0.6 |
| Cancer biotech Liminatus lines up $320M deal for new cell therapies - Stock Titan | Cancer biotech Liminatus lines up $320M deal for new cell therapies Stock Titan | View source ↗ | Stock Titan | May 21, 2026 | neutral | 0 | 0.6 |
| Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares - TechStock² | Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares TechStock² | View source ↗ | TechStock² | Feb 3, 2026 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Liminatus Pharma Inc. (LIMN) - Zacks Investment Research | What is the current Price Target and Forecast for Liminatus Pharma Inc. (LIMN) Zacks Investment Research | View source ↗ | Zacks Investment Research | Dec 27, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | May 5, 2025 | neutral | 0 | 0.6 |
| Liminatus Pharma, Inc. (LIMN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Liminatus Pharma, Inc. (LIMN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | May 1, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.